XFOR

X 4 Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 0/10
X 4 Pharmaceuticals sales and earnings growth
XFOR Growth
Good
  • Revenue Y/Y↓ -71.26%
  • EPS Y/Y↓ -250.23%
  • FCF Y/Y↑ 22.59%
X 4 Pharmaceuticals gross and profit margin trends
XFOR Profitability
Low
  • Gross margin ↑ 81.80%
  • EPS margin↓ -1106.30%
  • ROIC 5Y↓ -117.04%
X 4 Pharmaceuticals net debt vs free cash flow
XFOR Risk
Great
  • Debt / Equity↓ 0.5
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -10.3

X 4 Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks